SageView Advisory Group LLC Raises Holdings in Stryker Co. (NYSE:SYK)

SageView Advisory Group LLC lifted its holdings in shares of Stryker Co. (NYSE:SYK) by 17.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,627 shares of the medical technology company’s stock after acquiring an additional 237 shares during the period. SageView Advisory Group LLC’s holdings in Stryker were worth $515,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Stryker by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 30,665,520 shares of the medical technology company’s stock worth $8,379,967,000 after buying an additional 143,631 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Stryker by 5.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,541,845 shares of the medical technology company’s stock worth $3,755,782,000 after buying an additional 642,178 shares during the period. Morgan Stanley raised its stake in shares of Stryker by 4.4% during the 3rd quarter. Morgan Stanley now owns 5,315,227 shares of the medical technology company’s stock worth $1,452,493,000 after buying an additional 223,728 shares during the period. Franklin Resources Inc. raised its stake in shares of Stryker by 0.6% during the 4th quarter. Franklin Resources Inc. now owns 4,686,440 shares of the medical technology company’s stock worth $1,403,401,000 after buying an additional 29,209 shares during the period. Finally, Norges Bank acquired a new position in shares of Stryker during the 4th quarter worth approximately $1,260,562,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on SYK. UBS Group upped their target price on Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 1st. StockNews.com downgraded Stryker from a “buy” rating to a “hold” rating in a research note on Monday. Citigroup upped their target price on Stryker from $362.00 to $406.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Stifel Nicolaus increased their price objective on Stryker from $350.00 to $375.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Finally, Roth Mkm increased their price objective on Stryker from $348.00 to $405.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $370.58.

Stryker Stock Performance

NYSE SYK opened at $348.67 on Wednesday. The stock has a market cap of $132.83 billion, a PE ratio of 39.80, a P/E/G ratio of 2.71 and a beta of 0.92. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56. Stryker Co. has a twelve month low of $249.98 and a twelve month high of $361.41. The stock has a fifty day simple moving average of $336.74 and a 200-day simple moving average of $331.10.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The company had revenue of $5.24 billion during the quarter, compared to analysts’ expectations of $5.10 billion. During the same period last year, the business posted $2.14 EPS. Stryker’s revenue for the quarter was up 9.7% on a year-over-year basis. Equities analysts anticipate that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date of this dividend is Friday, June 28th. Stryker’s dividend payout ratio (DPR) is 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.